# Group B Streptococcus Infection and PROM Incidince

> **NCT06735703** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 150 (estimated)

## Conditions studied

- Premature Rupture of Fetal Membranes
- Group B Streptococcal Infection

## Interventions

- **DRUG:** To provide ampicillin sulbactam to pregnant women with premature rupture of membrane

## Key facts

- **NCT ID:** NCT06735703
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-25
- **Primary completion:** 2025-12-09
- **Final completion:** 2026-01-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06735703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06735703, "Group B Streptococcus Infection and PROM Incidince". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06735703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*